ADMA (asymmetric dimethylarginine): an atherosclerotic disease mediating agent in patients with renal disease?
Kielstein
J T
JT
Department of Nephrology, Hannover Medical School, Carl-Neuberg-Strasse 1, D-30625 Hannover, Germany.
Frölich
J C
JC
Haller
H
H
Fliser
D
D
D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives* / Q000502:physiology*; D001161:Arteriosclerosis / Q000209:etiology*; D004791:Enzyme Inhibitors / Q000378:metabolism; D006801:Humans; D007674:Kidney Diseases / Q000150:complications* / Q000503:physiopathology*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors*
D004791:Enzyme Inhibitors; C018524:N,N-dimethylarginine; D001120:Arginine; D019001:Nitric Oxide Synthase